Ftse Mib
38.655,30
1,73%
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
NASDAQ
17.754,09
2,61%
Bitcoin
83.788,36
-0,66%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Longboard Pharmaceuticals Inc (LBPH) Longboard Pharmaceuticals Inc (LBPH) Notizie

Longboard Pharmaceuticals Inc

LBPH
59,98
0,00 (0,00%)
14 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/12/202414:10EDGAR2Form 15-12G - Securities registration termination [Section..
10/12/202421:53EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
10/12/202421:40EDGAR2Form RW WD - Withdrawal of Registration Withdrawal Request
10/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
03/12/202401:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202417:30EDGAR2Form RW - Registration Withdrawal Request
02/12/202415:11EDGAR2Form S-8 POS - Securities to be offered to employees in..
02/12/202415:07EDGAR2Form POS AM - Post-Effective amendments for registration..
02/12/202415:07EDGAR2Form POS AM - Post-Effective amendments for registration..
02/12/202415:07EDGAR2Form POS AM - Post-Effective amendments for registration..
02/12/202415:05EDGAR2Form 8-K - Current report
29/11/202414:40EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
20/11/202414:01EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/11/202414:30BWLongboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study..
07/11/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:05EDGAR2Form 8-K - Current report
07/11/202422:01BWLongboard Pharmaceuticals Reports Third Quarter 2024..
06/11/202412:06EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
30/10/202413:57EDGAR2Form SC 14D9 - Solicitation, recommendation statements
22/10/202421:24EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
15/10/202415:17PRNUSKuehn Law Encourages PRMW, FBMS, EVRI, and LBPH Investors to..
15/10/202412:20EDGAR2Form SC14D9C - Written communication relating to third party..
15/10/202412:14EDGAR2Form 8-K - Current report
14/10/202423:47PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
14/10/202412:30BWLundbeck to Acquire Longboard Pharmaceuticals in a Strategic..
04/10/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
26/9/202414:30BWLongboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study..
19/9/202414:30BWLongboard Pharmaceuticals Receives Rare Pediatric Disease..
08/9/202412:30BWLongboard Pharmaceuticals Announces Positive Interim..
06/9/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
28/8/202422:00BWLongboard Pharmaceuticals to Participate in Four Upcoming..
26/8/202422:01BWLongboard Pharmaceuticals to Present Late-Breaking and..
26/8/202415:00BWLongboard Pharmaceuticals to Host Investor & Analyst Event..
02/8/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
01/8/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:10EDGAR2Form 8-K - Current report
01/8/202422:01BWLongboard Pharmaceuticals Reports Second Quarter 2024..
29/7/202415:15BWLongboard Pharmaceuticals to Report Second Quarter 2024..
03/7/202422:00BWLongboard Pharmaceuticals Announces Inducement Grants Under..
01/7/202415:00BWLongboard Pharmaceuticals Receives Breakthrough Therapy..
10/6/202415:05EDGAR2Form 8-K - Current report
10/6/202415:00BWLongboard Pharmaceuticals Announces Positive Interim Results..
03/6/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
24/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:05EDGAR2Form 8-K - Current report
06/5/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
02/5/202422:01BWLongboard Pharmaceuticals Reports First Quarter 2024..
03/4/202415:00BWLongboard Pharmaceuticals to Present Late-Breaking Data from..
02/4/202422:00BWLongboard Pharmaceuticals Announces Inducement Grants Under..
Apertura: Min: Max:
Chiusura: 59,98

La tua Cronologia

NASDAQ
LBPH
Longboard Pharmaceuticals
USOTC
UFHGF
Ultrafabrics (PK)
LSE
0GQ1
Electrolux Ab
LSE
45IS
Investec Bnk 24
LSE
ZP36
Barclays.27
NASDAQI
BIQ
ISE BICK
LSE
40XY
Paragon 12 A2bs
NASDAQ
PSET
Principal ETFs Principal...
NASDAQ
BLNG
Belong Acquisition
LSE
BO79
Citi Fun 26
LSE
AV82
Bank Mont.24
TSXV
RMB
Rumbu
USOTC
STKKF
Strike Energy (PK)
DOWI
DWCGAS
DJ US Gas Distribution T...
NASDAQ
PROP
Prairie Operating
TSXV
ORCS.P
Orcus Resources
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci